Financials

News Ideas Technicals

AVE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to AVECHO BIOTECHNOLOGY LIMITED operating, investing, and financing activities

AVE free cash flow for H2 23 is -2.78 M AUD. For 2023, AVE free cash flow was -3.18 M AUD and operating cash flow was -3.18 M AUD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—